Predictors of increased melphalan exposure correlate with overall survival, nonrelapse mortality, and toxicities in patients undergoing reduced-intensity allogeneic stem cell transplantation with fludarabine and melphalan.
J Oncol Pharm Pract
; 27(3): 579-587, 2021 Apr.
Article
in En
| MEDLINE
| ID: mdl-32493164
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Vidarabine
/
Antineoplastic Agents, Alkylating
/
Stem Cell Transplantation
/
Melphalan
/
Antineoplastic Agents
Type of study:
Observational_studies
/
Prognostic_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Oncol Pharm Pract
Journal subject:
FARMACIA
Year:
2021
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom